RGNX - リジェネックスバイオ （REGENXBIO Inc.）RGNXのニュース
REGENXBIO Announces Presentation at the Jefferies Global Healthcare Conference 2023/06/01 11:05:00 PR Newswire
ROCKVILLE, Md., June 1, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present and host one-on-one investor meetings at the Jefferies Global Healthcare Conference on Thursday, June 8, 2023. Jefferies Global Healthcare Conference Date: Thursday, June 8,…
Regenxbio''s gene therapy for Hunter syndrome gets FDA regenerative medicine status 2023/05/23 12:00:59 Seeking Alpha
The U.S. FDA granted Regenerative Medicine Advanced Therapy designation to Regenxbio''s (RGNX) gene therapy RGX-121 for Hunter syndrome. Read more here
REGENXBIO Announces NAV® Technology Platform Will Support Bespoke Gene Therapy Consortium''s First Rare Disease Clinical Portfolio 2023/05/16 21:52:00 Kwhen Finance
Regenxbio: Buy, High-Potential Stock Stagnant Due To No Near-Term Catalysts 2023/05/12 13:20:33 Seeking Alpha
Regenxbio has solid cash, a great partnership, and a pipeline with a lot of potential. Click here for more.
REGENXBIO Inc. (RGNX) Q1 2023 Earnings Call Transcript 2023/05/04 02:47:06 Seeking Alpha
REGENXBIO Inc. (NASDAQ:NASDAQ:RGNX) Q1 2023 Results Conference Call May 3, 2023 4:30 PM ETCompany ParticipantsPatrick Christmas - EVP and Chief Legal OfficerKen Mills - CEOSteve Pakola -…
REGENXBIO Inc (RGNX): Price Now Near $33.19; Daily Chart Shows Downtrend on 50 Day Basis 2021/09/01 15:19:07 ETF Daily News
The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment -- meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend. The post REGENXBIO Inc (RGNX): Price Now Near $33.19; Daily Chart Shows Downtrend on 50 Day Basis appeared first on ETF Daily News .
REGENXBIO Inc (RGNX): Price Up $0.13 (0.41)% Over Past Day, Up $0.12 (0.38)% Over Past Hour 2021/08/16 15:17:03 ETF Daily News
This is a reversal of the price action on the previous hour, in which price moved down. The post REGENXBIO Inc (RGNX): Price Up $0.13 (0.41)% Over Past Day, Up $0.12 (0.38)% Over Past Hour appeared first on ETF Daily News .
REGENXBIO Inc. (RGNX) CEO Ken Mills on Q2 2021 Results - Earnings Call Transcript 2021/08/10 03:31:05 Seeking Alpha
REGENXBIO Reports Second Quarter 2021 Financial Results and Operational Highlights 2021/08/09 20:05:00 PR Newswire
ROCKVILLE, Md., Aug. 9, 2021 /PRNewswire/ -- Enrollment in RGX-314 programs is on-track, including the pivotal program for the treatment of wet AMD utilizing subretinal delivery, and the Phase II trials for the treatment of wet AMD and DR utilizing in-office suprachoroidal delivery
REGENXBIO Reports Second Quarter 2021 Financial Results and Operational Highlights 2021/08/09 20:05:00 PR Newswire
ROCKVILLE, Md., Aug. 9, 2021 /PRNewswire/ -- Enrollment in RGX-314 programs is on-track, including the pivotal program for the treatment of wet AMD utilizing subretinal delivery, and the Phase II trials for the treatment of wet AMD and DR utilizing in-office suprachoroidal delivery
Gene Therapy For Cancer Market: Comprehensive Study Explore Huge Growth in Future | GLIEAD, REGENXBIO, Autolus 2021/07/29 15:07:00 iCrowdNewswire
The Gene Therapy For Cancer market research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with []